On June 2, European Union Health Ministers and Parliament adopted the action program on health promotion, information, education and training within the framework of public health, EU Commissioner Padraig Flynn told the 31st Annual Meeting of the European Proprietary Medicines Manufacturers' Association in Lisbon, Portugal, last week. The budget for this program has been set at 600 million Ecus ($781.4 million; see also Marketletter June 12).
This is a major step forward for the sector, and is the first time that an EU endorsement has been given to self-medication, explicitly in an official document on public health policy.
The support is not only for minor ailments, but also for chronic conditions which are initially diagnosed by the doctor and subsequently, with the right information, managed by the consumer with the help of a pharmacist. The move was welcomed by the AESGP.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze